Selecting the most appropriate formulation excipient for manufacture of amorphous solid dispersions: a case study of lumefantrine

Abstract

This work demonstrated the importance of pre-formulation studies and proposed a generalised scheme for excipient screening in the early stage of amorphous solid dispersion(ASD) system development by profiling the excipients’ capability to solubilise, amorphisise, and stabilise the chosen active pharmaceutical ingredient (API) in an effort to rank their suitability. Lumefantrine, an antimalarial active compound with both poor solubility and permeability, was used as a model API and solvent evaporation film casting was used to prepare the candidate ASD matrices in this work. 

Keywords

Amorphous solid dispersion, Polymer, Pre-formulation study, Drug enabling, amorphous solid dispersion

How to Cite

Liu, D., Li, S., Jones, D. & Andrews, G. P., (2022) “Selecting the most appropriate formulation excipient for manufacture of amorphous solid dispersions: a case study of lumefantrine”, British Journal of Pharmacy 7(2). doi: https://doi.org/10.5920/bjpharm.1156

446

Views

63

Downloads

Share

Authors

Dijia Liu (Queen's University Belfast)
Shu Li (Queen's University Belfast)
David Jones (Queen's University Belfast)
Gavin Paul Andrews (Queen's University Belfast)

Download

Issue

Dates

Licence

Creative Commons Attribution 4.0

Identifiers

File Checksums (MD5)

  • Full text: 9c670e29f5114d09c199ab79570819e8